FIGURE

Fig. 3

ID

ZDB-FIG-230614-3

Publication

Grissenberger et al., 2022 - High-content drug screening in zebrafish xenografts reveals high efficacy of dual MCL-1/BCL-X_L inhibition against Ewing sarcoma

Other Figures

All Figure Page

Back to All Figure Page

Fig. 3

Fig. 3. Single agent treatment of xenotransplanted larvae A) Schematic representation of the workflow - Zebrafish embryos were xenotransplanted with shSK-E17T Ewing sarcoma cells at 2 dpf. After 24 h (1 dpi) embryos were imaged on the Operetta CLS and subsequently incubated in respective amounts of small compounds. After 48 h (3 dpi) larvae were imaged again and changes in tumor size were analyzed. B-E) Xenotransplanted larvae were treated with irinotecan (100 μM, B), S63845 (10 μM, C), A-1331852 (10 μM, D) and YK-4-279 (10 μM, E) for 48 h (1 dpi - 3 dpi). Dot plots show relative changes of tumor area (3 dpi/1 dpi). Waterfall plots (right panels, 1 bar per zebrafish) total change in tumor area (3 dpi - 1 dpi). Scale bar is 125 μm. Statistical analyses were performed with a Mann-Whitney test, ****: p ≤ 0.0001, ***: p ≤ 0.001. Error bars represent SEM of combined larvae from two independent experiments.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Cancer Lett.